CSCO
63
2
M
20
-4
FMC
31
5
IR
63
3
RSG
68
3
EQR
54
-2
WAT
47
5
VFC
47
-5
HOG
29
-4
SO
55
-2
ACN
47
-2
DE
46
3
ZTS
47
2
MRK
22
3
AXP
66
2
AZO
46
-3
JNJ
41
2
GIS
26
3
DLTR
34
-4
EXR
57
-2
CSCO
63
2
M
20
-4
FMC
31
5
IR
63
3
RSG
68
3
EQR
54
-2
WAT
47
5
VFC
47
-5
HOG
29
-4
SO
55
-2
ACN
47
-2
DE
46
3
ZTS
47
2
MRK
22
3
AXP
66
2
AZO
46
-3
JNJ
41
2
GIS
26
3
DLTR
34
-4
EXR
57
-2
Financhill
Back

Genmab AS Vs. Galecto Industry Stock Comparison

Sell
25

GMAB
Genmab AS

Last Price:
20.48
Seasonality Move:
3.28%
Sell
17

GLTO
Galecto

Last Price:
5.75
Seasonality Move:
-0.96%
Sell
25
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $20.45. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Galecto (GLTO) is a Sell

Is Galecto a Buy, Sell or Hold?

  • The current Galecto [GLTO] share price is $5.81. The Score for GLTO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • GLTO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $20.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight selling pressure.

GLTO Stock Price Chart

What is Galecto's stock price today?

  • The Galecto share price today is $5.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLTO is experiencing selling pressure, which indicates risk of future bearish movement.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 25.28 Sell
Chaikin Money Flow: -57518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.45 - 23.25) Sell
Bollinger Bands (100): (23.03 - 27.51) Sell

GLTO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 25.82 Sell
Chaikin Money Flow: -1903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.44 - 7.26) Sell
Bollinger Bands (100): (0.83 - 10.43) Buy

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.34 Sell
20-day SMA: 22.22 Sell
50-day SMA: 23.4 Sell
200-day SMA: 26.95 Sell
8-day EMA: 21.16 Sell
20-day EMA: 22 Sell
50-day EMA: 23.31 Sell
200-day EMA: 26.81 Sell

GLTO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.5 Sell
20-day SMA: 6.84 Sell
50-day SMA: 8.95 Sell
200-day SMA: 3.15 Buy
8-day EMA: 6.34 Sell
20-day EMA: 6.85 Sell
50-day EMA: 7.18 Sell
200-day EMA: 4.34 Buy

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.

Galecto Earnings Growth & GLTO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.91 per share, and a decrease next year of $0.44 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Galecto Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):